Quent Capital, LLC Infinity Pharmaceuticals, Inc. Transaction History

Quent Capital, LLC

  • $950 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 14, 2024
BUY
$0.16 - $0.74 $15 - $69
94 New
94 $0
Q4 2022

Jan 19, 2023
SELL
$0.46 - $1.21 $137 - $360
-298 Reduced 76.02%
94 $0
Q1 2022

May 12, 2022
BUY
$0.85 - $2.4 $333 - $940
392 New
392 $0

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email